Clinical research collaboration formed in the US aims to match patients with trials
This article was originally published in SRA
A group of US medical centres has linked up with several healthcare companies and other stakeholders to form a collaborative effort that aims to "dramatically improve the speed and quality of clinical research necessary to develop new medicines"1.
You may also be interested in...
Perhaps only a man who inherited an enthusiasm for peptides could, without a trace of irony, cast diabetes drug development as the work of a pastry chef. But for David Solomon, the son of a peptide devotee, mixed metaphors and stretched comparisons are simply the spray thrown up by his unbridled enthusiasm for his chosen trade, that of basketball coach to GLP-1 receptor agonist developer Zealand Pharma.
"How the hell will Glaxo need you? You've only got a few people, they've got about 50,000!"